ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

Program Announcements

July 25, 1986

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009